Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010
- PMID: 24633360
- PMCID: PMC4896528
- DOI: 10.4161/hv.28389
Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010
Abstract
Studies assessing the economic burden of a mumps outbreak in a highly vaccinated population are limited. The Orange County Health Department (OCHD), New York State Department of Health (NYS DOH), and the Centers for Disease Control and Prevention conducted a mumps investigation in an affected village with a highly vaccinated population. To understand the epidemiology, standardized mumps case definition and active surveillance were used to identify mumps cases. In addition, an economic assessment of a combined outbreak investigation and third dose measles-mumps-rubella (MMR) vaccine intervention conducted by OCHD and NYS DOH was performed; estimated by retrospectively evaluating public health response-related activities including use of a third dose of MMR vaccine. From September 24, 2009, through June 15, 2010, 790 mumps cases were reported-64% were male and highest attack rate was among 11-17 year age group (99.1 cases per 1000 individuals). Of the 658 cases with known vaccination history, 83.6% had documentation of 2 doses of mumps containing vaccine. No deaths were reported. The 2 major exposure settings were schools (71.8%) and households (22.5%). Approximately 7736 h of public health personnel time were expended with the total approximate cost of US $463,000, including US $34,392 for MMR vaccine-the estimated cost per household was US $827. Mumps continues to be endemic in many parts of the world, resulting in importations into the United States. Large mumps outbreaks similar to this in highly vaccinated populations may require considerable investigation and control activities.
Keywords: economic; highly vaccinated; mumps; outbreak; vaccine.
Figures
Similar articles
-
Economic impact of the 2009-2010 Guam mumps outbreak on the public health sector and affected families.Vaccine. 2012 Oct 5;30(45):6444-8. doi: 10.1016/j.vaccine.2012.08.001. Epub 2012 Aug 14. Vaccine. 2012. PMID: 22902678
-
Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010.Pediatr Infect Dis J. 2013 Apr;32(4):374-80. doi: 10.1097/INF.0b013e318279f593. Pediatr Infect Dis J. 2013. PMID: 23099425 Free PMC article.
-
Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.Vaccine. 2013 May 31;31(24):2661-6. doi: 10.1016/j.vaccine.2013.04.014. Epub 2013 Apr 17. Vaccine. 2013. PMID: 23602654
-
Measles, mumps, rubella prevention: how can we do better?Expert Rev Vaccines. 2021 Jul;20(7):811-826. doi: 10.1080/14760584.2021.1927722. Epub 2021 Jun 7. Expert Rev Vaccines. 2021. PMID: 34096442 Review.
-
Mumps outbreak among young people in Northern Ireland.Commun Dis Public Health. 2001 Dec;4(4):311-5. Commun Dis Public Health. 2001. PMID: 12109401 Review.
Cited by
-
Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.N Engl J Med. 2017 Sep 7;377(10):947-956. doi: 10.1056/NEJMoa1703309. N Engl J Med. 2017. PMID: 28877026 Free PMC article.
-
Nationwide and long-term molecular epidemiologic studies of mumps viruses that circulated in Japan between 1986 and 2017.Front Microbiol. 2022 Oct 28;13:728831. doi: 10.3389/fmicb.2022.728831. eCollection 2022. Front Microbiol. 2022. PMID: 36386684 Free PMC article.
-
2016-2017 Arkansas mumps outbreak in a close-knit community: Assessment of the economic impact and response strategies.Vaccine. 2020 Feb 5;38(6):1481-1485. doi: 10.1016/j.vaccine.2019.11.066. Epub 2019 Dec 6. Vaccine. 2020. PMID: 31818532 Free PMC article.
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2020 Apr 20;4(4):CD004407. doi: 10.1002/14651858.CD004407.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Nov 22;11:CD004407. doi: 10.1002/14651858.CD004407.pub5. PMID: 32309885 Free PMC article. Updated.
-
Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases.Hum Vaccin Immunother. 2015;11(6):1413-7. doi: 10.1080/21645515.2015.1021522. Hum Vaccin Immunother. 2015. PMID: 25874726 Free PMC article.
References
-
- Centers for Disease Control (CDC). . Measles prevention. MMWR Morb Mortal Wkly Rep 1989; 38:Suppl 9 1 - 18; PMID: 2513473 - PubMed
-
- Centers for Disease Control and Prevention (CDC). . Notice to readers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for the control and elimination of mumps. MMWR Morb Mortal Wkly Rep 2006; 55:629 - 30; PMID: 16761359 - PubMed
-
- Vandermeulen C, Leroux-Roels G, Hoppenbrouwers K. . Mumps outbreaks in highly vaccinated populations: What makes good even better?. Hum Vaccin 2009; 5:494 - 6; PMID: 19279405 - PubMed
-
- Brockhoff HJ, Mollema L, Sonder GJ, Postema CA, van Binnendijk RS, Kohl RH, de Melker HE, Hahné SJ. . Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine 2010; 28:2932 - 6; http://dx.doi.org/10.1016/j.vaccine.2010.02.020; PMID: 20188683 - DOI - PubMed
-
- Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, Hunt K, Finley CG, Leschinsky DP, O’Keefe AL, et al. . . Recent resurgence of mumps in the United States. N Engl J Med 2008; 358:1580 - 9; http://dx.doi.org/10.1056/NEJMoa0706589; PMID: 18403766 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical